| Literature DB >> 34035928 |
Weikai Huang1, Xiaoying Tang1.
Abstract
Large deformation diffeomorphic metric mapping for curve (LDDMM-curve) has been widely used in deformation based statistical shape analysis of the mid-sagittal corpus callosum. A main limitation of LDDMM-curve is that it is time-consuming and computationally complex. In this study, down-sampling strategies for accelerating LDDMM-curve are investigated and tested on two large datasets, one on Alzheimer's disease (155 Alzheimer's disease, 325 mild cognitive impairment and 185 healthy controls) and the other on first-episode schizophrenia (92 first-episode schizophrenia and 106 healthy controls). For both datasets a variety of down-sampling factors are tested in terms of registration accuracy, registration speed, and most importantly disease-related patterns. Experimental results revealed that down-sampling template curve by a factor of 2 can significantly reduce the running time of LDDMM-curve without sacrificing the registration accuracy. Also, the disease-induced patterns, or more specifically the group comparison results, were almost identical before and after down-sampling. It is also shown that there was no need to down-sample the target population curves but only the single template curve of the study of interest. Comprehensive analyses were conducted.Entities:
Year: 2021 PMID: 34035928 PMCID: PMC8136766 DOI: 10.1049/htl2.12011
Source DB: PubMed Journal: Healthc Technol Lett ISSN: 2053-3713
FIGURE 1Block diagram of the entire pipeline
Registration performance results obtained on the first dataset
| Down‐sampling factor | Running time (s/target curve) | Dice score | Dice |
|---|---|---|---|
| Original | 18.5 | 0.89 | / |
| 2(template and target) | 4.57 | 0.893 | 0.005 |
| 2(only template) | 4.72 | 0.895 |
|
| 3(template and target) | 2.19 | 0.887 | 3.43 |
| 3(only template) | 2.29 | 0.891 | 3.57 |
| 4(template and target) | 1.36 | 0.886 | 4.55 |
| 4(only template) | 1.54 | 0.889 | 8.07 |
| 5(template and target) | 1.03 | 0.876 | 1.94 |
| 5(only template) | 1.20 | 0.884 | 3.35 |
Bold typesetting indicates no significance from Student's t‐test.
Registration performance results obtained on the second dataset
| Down‐sampling factor | Running time (s/target curve) | Dice score | Dice |
|---|---|---|---|
| Original | 16.45 | 0.926 | / |
| 2(template and target) | 4.52 | 0.922 | 0.020 |
| 2(only template) | 4.57 | 0.923 |
|
| 3(template and target) | 2.34 | 0.919 | 4.13 |
| 3(only template) | 2.44 | 0.922 | 0.023 |
| 4(template and target) | 1.41 | 0.917 | 1.60 |
| 4(only template) | 1.52 | 0.920 |
|
| 5(template and target) | 1.04 | 0.910 | 8.41 |
| 5(only template) | 1.27 | 0.917 | 1.02 |
Bold typesetting indicates no significance from Student's t‐test.
The overall error obtained from comparing the localised shape difference result under each down‐sampling factor and that of the original result on the first and second datasets
| HC vs. Disease group | |||
|---|---|---|---|
| Down‐sampling factor | MCI | AD | FES |
| 2(template and target) | 3.12% | 4.83% | 4.28% |
| 2(only template) |
|
|
|
| 3(template and target) | 4.77% | 2.15% | 4.94% |
| 3(only template) | 4.70% | 7.45% | 4.70% |
| 4(template and target) | 9.26% | 11.04% | 5.54% |
| 4(only template) | 6.43% | 7.08% | 7.91% |
| 5(template and target) | 37.48% | 7.00% | 7.36% |
| 5(only template) | 7.24% | 10.94% | 8.00% |
Bold typesetting suggests the best result.
FIGURE 2The localised shape analysis results of the first dataset. A demonstrates the original results, B demonstrates results after down‐sampling the template curve by a factor of 2 and C demonstrates up‐sampled results of B. The CC sub‐region definitions are illustrated at the bottom panel. The color bar denotes the degree of atrophy in the patient group relative to the control group
FIGURE 3The localised shape analysis results of the second dataset. A demonstrates the original results, B demonstrates results after down‐sampling the template curve by a factor of 2 and C demonstrates up‐sampled results of B. The CC sub‐region definitions are illustrated at the bottom panel. The color bar denotes the degree of atrophy in the patient group relative to the control group